Chemoinformaics analysis of 24-nor-cholest-5,22E-dien-3beta-ol
Molecular Weight | 370.621 | nRot | 3 |
Heavy Atom Molecular Weight | 328.285 | nRig | 21 |
Exact Molecular Weight | 370.324 | nRing | 4 |
Solubility: LogS | -6.512 | nHRing | 0 |
Solubility: LogP | 6.693 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 69 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 26 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 72.2273 |
nHD | 1 | BPOL | 42.1347 |
QED | 0.543 |
Synth | 4.39 |
Natural Product Likeliness | 2.88 |
NR-PPAR-gamma | 0.008 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.826 |
Pgp-sub | 0.825 |
HIA | 0.007 |
CACO-2 | -4.555 |
MDCK | 0.0000176 |
BBB | 0.244 |
PPB | 0.923201 |
VDSS | 1.287 |
FU | 0.0197308 |
CYP1A2-inh | 0.148 |
CYP1A2-sub | 0.549 |
CYP2c19-inh | 0.21 |
CYP2c19-sub | 0.928 |
CYP2c9-inh | 0.344 |
CYP2c9-sub | 0.223 |
CYP2d6-inh | 0.142 |
CYP2d6-sub | 0.664 |
CYP3a4-inh | 0.651 |
CYP3a4-sub | 0.605 |
CL | 4.036 |
T12 | 0.064 |
hERG | 0.043 |
Ames | 0.004 |
ROA | 0.171 |
SkinSen | 0.917 |
Carcinogencity | 0.078 |
EI | 0.47 |
Respiratory | 0.693 |
NR-Aromatase | 0.041 |
Antiviral | No |
Prediction | 0.704444 |